Bellerophon Therapeutics Inc
(BLPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,731 | 20,103 | 24,839 | 28,817 | 34,403 |
| TOTAL | $16,988 | $20,516 | $25,459 | $29,715 | $35,293 |
| Non-Current Assets | |||||
| PPE Net | 27 | 46 | 67 | 88 | 112 |
| Other Non-Current Assets | 715 | 1,183 | 1,349 | 1,512 | 1,674 |
| TOTAL | $742 | $1,229 | $1,416 | $1,600 | $1,786 |
| Total Assets | $17,730 | $21,745 | $26,875 | $31,315 | $37,079 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,007 | 2,193 | 1,192 | 1,278 | 2,484 |
| Accrued Expenses | 2,856 | 2,608 | 3,108 | 3,109 | 3,016 |
| TOTAL | $5,449 | $5,566 | $5,052 | $5,127 | $6,228 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1 | 9 | 204 | 397 | 754 |
| TOTAL | $1 | $9 | $204 | $397 | $754 |
| Total Liabilities | $5,450 | $5,575 | $5,256 | $5,524 | $6,982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,545 | 9,545 | 9,545 | 9,506 | 9,506 |
| Common Shares | 95 | 95 | 95 | 95 | 95 |
| Retained earnings | -241,993 | -237,888 | -232,247 | -227,975 | -223,341 |
| TOTAL | $12,280 | $16,170 | $21,619 | $25,791 | $30,097 |
| Total Liabilities And Equity | $17,730 | $21,745 | $26,875 | $31,315 | $37,079 |